🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

140,24 USD

Máx. histórico

158,62

78 días

Caída desde máximo

-11,59%

Rango 52 semanas

75,44 – 160,81

Variación hoy

+0,62%

Cierre anterior

139,37

Rango de hoy

139,91 – 144,27

Volumen hoy

673.087

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,34%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
136,16 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 11 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
02/04/2018 8,62 8,97 8,01 8,29 -3,49% 11,13% 244.900
29/03/2018 8,51 8,97 8,10 8,59 +1,54% 10,22% 302.300
28/03/2018 8,99 9,17 8,39 8,46 -6,31% 8,68% 314.100
27/03/2018 8,73 9,24 8,60 9,03 +3,20% 7,33% 726.800
26/03/2018 7,86 9,75 7,85 8,75 -57,17% 24,17% 4.733.900
23/03/2018 19,61 21,26 19,26 20,43 +3,55% 10,21% 256.300
22/03/2018 20,33 20,87 19,55 19,73 -3,33% 6,52% 122.600
21/03/2018 20,51 20,87 20,23 20,41 -0,78% 3,12% 76.100
20/03/2018 20,57 20,84 20,27 20,57 -0,19% 2,77% 63.000
19/03/2018 20,20 20,86 20,13 20,61 +1,53% 3,61% 69.300
16/03/2018 20,50 20,65 19,80 20,30 -1,41% 4,15% 307.400
15/03/2018 20,48 21,03 20,12 20,59 +0,88% 4,44% 66.100
14/03/2018 20,77 20,77 19,92 20,41 -1,26% 4,09% 42.100
13/03/2018 21,09 21,18 20,45 20,67 -1,29% 3,44% 62.800
12/03/2018 23,10 23,10 20,69 20,94 -9,27% 10,43% 185.800
09/03/2018 20,21 23,97 19,34 23,08 +14,09% 22,91% 224.900
08/03/2018 20,84 21,00 19,80 20,23 -3,16% 5,76% 90.900
07/03/2018 20,55 21,22 20,18 20,89 +1,16% 5,06% 89.500
06/03/2018 19,84 20,75 19,09 20,65 +4,24% 8,37% 250.800
05/03/2018 20,50 20,50 18,93 19,81 -5,03% 7,66% 137.800
02/03/2018 17,16 21,90 16,70 20,86 +19,82% 30,30% 267.900
01/03/2018 17,28 17,68 16,57 17,41 +2,71% 6,42% 242.700
28/02/2018 17,00 17,53 16,86 16,95 -0,64% 3,94% 122.000
27/02/2018 17,18 17,55 16,68 17,06 -1,10% 5,06% 68.200
26/02/2018 17,53 17,84 16,94 17,25 -1,20% 5,13% 35.500
23/02/2018 17,09 17,84 16,59 17,46 +3,37% 7,31% 60.900
22/02/2018 18,00 18,00 16,80 16,89 -6,01% 6,67% 75.200
21/02/2018 16,57 18,00 16,57 17,97 +8,58% 8,63% 126.500
20/02/2018 17,39 17,52 16,32 16,55 -5,81% 6,90% 83.400
16/02/2018 17,57 18,19 17,50 17,57 -0,51% 3,93% 61.500